GI Dynamics
About Us
Learn About EndoBarrier
Non-Surgical Therapeutics
Type 2 Diabetes and Obesity
Media Center
Investors
Contact Us
For Media
For Investors
The EndoBarrier has received CE mark approval in Europe and has received an investigational device exemption to permit a pilot clinical trial in the United States.